Additionally, some scholars have found that knocking out S-phase kinase-associated protein 2 (Skp2) could inhibit HK2 expression and glycolysis, and thereby limit the growth of colorectal cancer cells in vivo and in vitro. Here, SKP2 is linked to colorectal cancer.